Dionysios Chartoumpekis

Summary

Affiliation: University of Patras
Country: Greece

Publications

  1. doi Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway
    Dionysios Chartoumpekis
    Department of Internal Medicine, School of Medicine, University of Patras, 26500 Patras, Greece
    Biochem Biophys Res Commun 396:463-6. 2010
  2. doi Simvastatin activates Keap1/Nrf2 signaling in rat liver
    Ioannis G Habeos
    Department of Internal Medicine, School of Medicine, University of Patras, 26500, Patras, Greece
    J Mol Med (Berl) 86:1279-85. 2008
  3. ncbi Fibrocalculous pancreatic diabetes in patient residing in the Mediterranean region
    Ioannis Habeos
    Division of Endocrinology and Diabetes, Department of Internal Medicine, Patras University Medical School, Greece
    Hormones (Athens) 5:64-6. 2006

Collaborators

Detail Information

Publications3

  1. doi Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway
    Dionysios Chartoumpekis
    Department of Internal Medicine, School of Medicine, University of Patras, 26500 Patras, Greece
    Biochem Biophys Res Commun 396:463-6. 2010
    ..We show for the first time that simvastatin lowers reactive oxygen species (ROS) by activating Nrf2 through the PI3K/Akt pathway...
  2. doi Simvastatin activates Keap1/Nrf2 signaling in rat liver
    Ioannis G Habeos
    Department of Internal Medicine, School of Medicine, University of Patras, 26500, Patras, Greece
    J Mol Med (Berl) 86:1279-85. 2008
    ..In conclusion, activation of Keap1/Nrf2 signaling pathway by simvastatin might provide effective protection of the cell from the deleterious effects of oxidative stress...
  3. ncbi Fibrocalculous pancreatic diabetes in patient residing in the Mediterranean region
    Ioannis Habeos
    Division of Endocrinology and Diabetes, Department of Internal Medicine, Patras University Medical School, Greece
    Hormones (Athens) 5:64-6. 2006
    ..This case accords with the criteria for fibrocalculous pancreatic diabetes with the unique feature of the patient having been born in Greece and being a resident of Greece...